Korro Bio Inc — Quarterly Financial Statistics (NASDAQ:KRRO) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 16.09 M7.5 M24.45 M19.23 M17.18 M 68.35 M Cash from investing activities 12.58 M2.77 M32.78 M-11.3 M7.6 M 31.84 M Cash from financing activities 728 K932 K172 K5 000128 K 1.24 M Free cash flow 11.22 M6.04 M24.33 M19.09 M17 M 66.47 M

Haberler

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

코로 바이오, 고암모니아혈증 프로그램 잠재력에 Clear Street, 투자의견 상향

Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

코로 바이오, HC 웨인라이트, 신약 잠재력에 매수 등급으로 상향

Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential

파이퍼 샌들러, 코로 바이오 투자의견 ’비중확대’로 상향...UCD 치료제 주목

Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment

Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential

Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28

윌리엄 블레어, 코로 바이오에 대해 ’Market Perform’ 등급 유지

레이먼드 제임스, 코로 바이오에 ’시장 수익률’ 등급 유지